Injection techniques for botulinum toxin using electromyography and electrical stimulation

Muscle and Nerve

Volumn 20, Issue SUPPL. 6, 1997, Pages

  O'Brien, Christopher F ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Colorado Neurological Institute ^*  (United States)

Author keywords

Botulinum toxin; Electrical stimulation; Electromyography; Spasticity management

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN;

ELECTROMYOGRAPHY; ELECTROSTIMULATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; NEUROMUSCULAR DISEASE; REVIEW;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HUMANS; INJECTIONS, INTRAMUSCULAR; NEUROMUSCULAR DISEASES;

EID: 33748268910     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4598(1997)6+<176::aid-mus12>3.0.co;2-4     Document Type: Article

References (12)

1. Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA: Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996;61(1):30-35.
2. Borodic GE, Ferrante R, Pearce LB, Smith K: Histologic assessment of dose related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9(1):31-39.
3. Borodic G, Johnson E, Goodnough M, Schantz E: Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology 1996;46(1):26-29.
4. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A: A randomised, double-blind, placebo-controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61(3):265-269.
5. Cornella CL, Buchman AS, Tanner CM, Brown Toms NC, Goetz CG: Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992;42(4):878-882.
6. Geenen C, Consky E, Ashby P: Localizing muscles for botulinum toxin treatment of focal hand dystonia. Can J Neurol Sci 1996;23(3):194-197.
7. Greene P, Fahn S, Diamond B: Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994; 9(2):213-217.
8. Pierson SH, Katz DI, Tarsy D: Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil 1996;77:(7):313-321.
9. Shaari CM, Sanders A. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993;16:964-969.
10. Simpson DM, Alexander MD, O'Brien CF, Tagliati M, Aswad A, Leon JM, Gibson J, Mordant JM, Monaghan E: Bolulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996:46(5):1306-1310.
11. Snow BJ, Tsui JKC, Bhatt MH, et al: Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-515.
12. Yablon SA, Agana BT, Ivanhoe CB, Boake C: Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open labeled trial. Neurology 1996;47(4):939-944.